title: Successful eradication of inhibitor of late recurrence and other high risk prognostic factors in a patient with severe haemophilia A.
authors.forename: S
authors.initials: S
authors.lastname: Ranta
authors.forename: S
authors.initials: S
authors.lastname: Koskinen
authors.forename: A
authors.initials: A
authors.lastname: Mäkipernaa
mesh_terms: D000293:Adolescent; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D019774:Blood Coagulation Factor Inhibitors / Q000032:analysis*; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D019774:Blood Coagulation Factor Inhibitors; D007155:Immunologic Factors; D011994:Recombinant Proteins; D000069283:Rituximab; D005169:Factor VIII